Pathogenesis of intra-abdominal and pelvic adhesion development

Seminars in Reproductive Medicine

Volumn 26, Issue 4, 2008, Pages 289-297

  Imudia, Anthony N ^a   Kumar, Sanjeev ^a   Saed, Ghassan M ^b   Diamond, Michael P ^a,b,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

Adhesion re formation; De novo adhesion formation; Development; Intra abdominal; Pathogenesis; Pelvic; Postoperative adhesions

Indexed keywords

BLOOD CLOTTING FACTOR; CELL ADHESION MOLECULE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL INJURY; ABDOMINAL PAIN; ALLERGIC REACTION; ANGIOGENESIS; APOPTOSIS; CELL PROLIFERATION; CHEMICAL INJURY; DESICCATION; DISEASE COURSE; EXTRACELLULAR MATRIX; FIBRINOLYSIS; FOREIGN BODY; HUMAN; INFECTION; INFERTILITY; IRRADIATION; LEUKOCYTE; MACROPHAGE; MESOTHELIUM CELL; MOLECULAR BIOLOGY; MORBIDITY; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PELVIC ADHESION; PELVIC DISEASE; PELVIS PAIN SYNDROME; PERITONEAL CAVITY; PERITONEAL FLUID; PERITONEUM ADHESION; REVIEW; SMALL INTESTINE OBSTRUCTION; SURGICAL INJURY;

ABDOMEN; ADHESIONS; ANTI-INFLAMMATORY AGENTS; ASCITIC FLUID; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MODELS, BIOLOGICAL; PELVIS; PERITONEAL DISEASES; POSTOPERATIVE COMPLICATIONS; SIGNAL TRANSDUCTION;

EID: 50249136764     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1082387     Document Type: Review

References (105)

1. Diamond MP, Freeman ML. Clinical implications of postsurgical adhesions. Hum Reprod Update 2001;7:567-576
2. Davey AK, Maher PJ. Surgical adhesions: a timely update, a great challenge for the future. J Minim Invasive Gynecol 2007;14:15-22
3. Imudia AN, Diamond MP. Endometriosis and adhesion. Available at: http://wes.endometriosis.org/WES%20e-Journal%202007%201Q.pdf. Accessed October 20, 2007
4. Douvdevani A, Rapoport J, Konforty A, Argov S, Ovnat A, Chaimovitz C. Human peritoneal mesothelial cells synthesize IL-1 alpha and beta. Kidney Int 1994;46:993-1001
5. Bachus KE, Doty E, Haney AF, Weinberg JB. Differential effects of interleukin-1 alpha, tumor necrosis factor-alpha, indomethacin, hydrocortisone, and macrophage co-culture on the proliferation of human fibroblasts and peritoneal mesothelial cells. J Soc Gynecol Investig 1995;2:636-642
6. Offner FA, Obrist P, Stadimann S, et al. IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells. Cytokine 1995;7:542-547
7. Arici A, Tazuke SI, Attar E, Kliman HJ, Olive DL. Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum Reprod 1996; 2:40-45
8. Saed GM, Zhang W, Diamond MP. Molecular characterization of fibroblasts isolated from human peritoneum and adhesions. Fertil Steril 2001;75:763-768
9. Bachus KE, Doty E, Haney AF, Weinberg JB. Differential effects of interleukin-1 alpha, tumor necrosis factor-alpha, indomethacin, hydrocortisone, and macrophage co-culture on the proliferation of human fibroblasts and peritoneal mesothelial cells. J Soc Gynecol Investig 1995;2:636-642
10. Offner FA, Feichtinger H, Stadimann S, et al. Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1. Am J Pathol 1996;148:1679-1688
11. Chegini N. The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta). Eur J Surg Suppl 1997;579:17-23
12. Saed GM, Zhang W, Chegini N, Holmdahl L, Diamond MP. Transforming growth factor beta isoforms production by human peritoneal mesothelial cells after exposure to hypoxia. Am J Reprod Immunol 2000;43:285-291
13. Freeman ML, Saed GM, Elhammady EF, Diamond MP. Expression of transforming growth factor beta isoform mRNA in injured peritoneum that healed with adhesions and without adhesions and in uninjured peritoneum. Fertil Steril 2003;80(Suppl 2):708-713
14. Breborowicz A, Rodela H, Karon J, Martis L, Oreopoulos DG. In vitro simulation of the effect of peritoneal dialysis solution on mesothelial cells. Am J Kidney Dis 1997;29: 404-409
15. Van Hinsberg V, Kooistra T, Scheffer MA, Hajo van BJ, van Muijen GN. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 1990;75:1490-1497
16. Sitter T, Spannagl M, Schiffl H, Held E, Van Hinsberg V, Kooistra T. Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: the role of mesothelial cells. Nephrol Dial Transplant 1995;10: 677-683
17. Diamond MP, El-Hammady E, Wang R, Kruger M, Saed G. Regulation of expression of tissue plasminogen activator and plasminogen activator inhibitor-1 by dichloroacetic acid in human fibroblasts from normal peritoneum and adhesions. Am J Obstet Gynecol 2004;190:926-934
18. Saed GM, Abu-Soud HM, Diamond MP. Role of nitric oxide in apoptosis of human peritoneal and adhesion fibroblasts after hypoxia. Fertil Steril 2004;82(Suppl 3): 1198-1205
19. Liberek T, Topley N, Luttmann W, Williams JD. Adherence of neutrophils to human peritoneal mesothelial cells: role of intercellular adhesion molecule-1. J Am Soc Nephrol 1996;7:208-217
20. Chegini N, Kotseos K, Ma C, et al. Differential expression of integrin alpha v and beta 3 in serosal tissue of human intraperitoneal organs and adhesion. Fertil Steril 2001;75: 791-796
21. Yung S, Coles GA, Davies M. IL-1 beta, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: relevance to peritonitis in CAPD. Kidney Int 1996;50:1337-1343
22. Svinarich DM, Zaher FM, Holmdahl L, Chegini N, Gonik B, Diamond MP. Adhesion development and the expression of endothelial nitric oxide synthase. Infect Dis Obstet Gynecol 2001;9:113-116
23. Topley N, Petersen MM, Mackenzie R, et al. Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines. Kidney Int 1994;46:900-909
24. Syrop CH, Halme J. Cyclic changes of peritoneal fluid parameters in normal and infertile patients. Obstet Gynecol 1987;69:416-418
25. Olive DL, Haney AF, Weinberg JB. The nature of the intraperitoneal exudate associated with infertility: peritoneal fluid and serum lysozyme activity. Fertil Steril 1987;48:802-806
26. Ellis H. The aetiology of post-operative abdominal adhesions. An experimental study. Br J Surg 1962;50:10-16
27. Raftery AT. Regeneration of parietal and visceral peritoneum in the immature animal: a light and electron microscopical study. Br J Surg 1973;60:969-975
28. Haney AF, Doty E. The formation of coalescing peritoneal adhesions requires injury to both contacting peritoneal surfaces. Fertil Steril 1994;61:767-775
29. Milligan DW, Raftery AT. Observations on the pathogenesis of peritoneal adhesions: a light and electron microscopical study. Br J Surg 1974;61:274-280
30. Kligman I, Drachenberg C, Papadimitriou J, Katz E. Immunohistochemical demonstration of nerve fibers in pelvic adhesions. Obstet Gynecol 1993;82:566-568
31. Tulandi T, Chen MF, Al-Took S, Watkin K. A study of nerve fibers and histopathology of postsurgical, postinfectious, and endometriosis-related adhesions. Obstet Gynecol 1998;92:766-768
32. Saed GM, Diamond MP. Hypoxia-induced irreversible upregulation of type I collagen and transforming growth factor-beta1 in human peritoneal fibroblasts. Fertil Steril 2002;78:144-147
33. Saed GM, Diamond MP. Apoptosis and proliferation of human peritoneal fibroblasts in response to hypoxia. Fertil Steril 2002;78:137-143
34. Jones PA, Werb Z. Degradation of connective tissue matrices by macrophages. II. Influence of matrix composition on proteolysis of glycoproteins, elastin, and collagen by macrophages in culture. J Exp Med 1980;152:1527-1536
35. van der Poll T, Levi M, Buller HR, et al. Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 1991;174:729-732
36. Hau T, Payne WD, Simmons RL. Fibrinolytic activity of the peritoneum during experimental peritonitis. Surg Gynecol Obstet 1979;148:415-418
37. Holmdahl L, Falkenberg M, Ivarsson ML, Risberg B. Plasminogen activators and inhibitors in peritoneal tissue. APMIS 1997;105:25-30
38. Porter JM, McGregor FH Jr, Mullen DC, Silver D. Fibrinolytic activity of mesothelial surfaces. Surg Forum 1969;20:80-82
39. Raftery AT. Method for measuring fibrinolytic activity in a single layer of cells. J Clin Pathol 1981;34:625-629
40. Thompson JN, Paterson-Brown S, Harbourne T, Whawell SA, Kalodiki E, Dudley HA. Reduced human peritoneal plasminogen activating activity: possible mechanism of adhesion formation. Br J Surg 1989;76:382-384
41. Rout UK, Diamond MP. Role of plasminogen activators during healing after uterine serosal lesioning in the rat. Fertil Steril 2003;79:138-145
42. Vipond MN, Whawell SA, Thompson JN, Dudley HA. Effect of experimental peritonitis and ischaemia on peritoneal fibrinolytic activity. Eur J Surg 1994;160:471-477
43. Diamond MP, El-Hammady E, Wang R, Kruger M, Saed G. Regulation of expression of tissue plasminogen activator and plasminogen activator inhibitor-1 by dichloroacetic acid in human fibroblasts from normal peritoneum and adhesions. Am J Obstet Gynecol 2004;190:926-934
44. Holmdahl LE, Al-Jabreen M, Risberg B. Role of fibrinolysis in the formation of postoperative adhesions. Wound Repair Regen 1994;2:171-176
45. Ivarsson ML, Holmdahl L, Falk P, Molne J, Risberg B. Characterization and fibrinolytic properties of mesothelial cells isolated from peritoneal lavage. Scand J Clin Lab Invest 1998;58:195-203
46. Saed GM, Diamond MP. Modulation of the expression of tissue plasminogen activator and its inhibitor by hypoxia in human peritoneal and adhesion fibroblasts. Fertil Steril 2003;79:164-168
47. Koks CA, Groothuis PG, Slaats P, Dunselman GA, de Goeij AF, Evers JL. Matrix metalloproteinases and their tissue inhibitors in antegradely shed menstruum and peritoneal fluid. Fertil Steril 2000;73:604-612
48. Sharpe-Timms KL, Keisler LW, McIntush EW, Keisler DH. Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin-releasing hormone agonist therapy. Fertil Steril 1998;69: 1128-1134
49. Chegini N, Kotseos K, Bennett B, Diamond MP, Holmdahl L, Burns J. Matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in peritoneal fluids and sera and correlation with peritoneal adhesions. Fertil Steril 2001; 76:1207-1211
50. Sharpe-Timms KL, Zimmer RL, Jolliff WJ, Wright JA, Nothnick WB, Curry TE. Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation. Fertil Steril 1998;69:916-923
51. Saed GM, Diamond MP. Effects of interferon-gamma reverse hypoxia-stimulated extracellular matrix expression in human peritoneal and adhesion fibroblasts. Fertil Steril 2006;85(Suppl 1):1300-1305
52. Saed GM, Zhang W, Diamond MP. Molecular characterization of fibroblasts isolated from human peritoneum and adhesions. Fertil Steril 2001;75:763-768
53. Ma C, Tarnuzzer RW, Chegini N. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-beta1. Wound Repair Regen 1999;7:477-485
54. Sharpe-Timms KL, Zimmer RL, Jolliff WJ, Wright JA, Nothnick WB, Curry TE. Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation. Fertil Steril 1998;69:916-923
55. Diamond MP, El-Hammady E, Wang R, Saed G. Regulation of matrix metalloproteinase-1 and tissue inhib-itor of matrix metalloproteinase-1 by dichloroacetic acid in human fibroblasts from normal peritoneum and adhesions. Fertil Steril 2004;81:185-190
56. Sato Y, Rifkin DB. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol 1989;109:309-315
57. Parks WC. Matrix metalloproteinases in repair. Wound Repair Regen 1999;7:423-432
58. Roberts AB. Transforming growth factor-beta: activity and efficacy in animal models of wound healing. Wound Repair Regen 1995;3:408-418
59. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 1983;258:7155-7160
60. Assoian RK, Fleurdelys BE, Stevenson HC, et al. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987;84:6020-6024
61. Cromack DT, Sporn MB, Roberts AB, Merino MJ, Dart LL, Norton JA. Transforming growth factor beta levels in rat wound chambers. J Surg Res 1987;42:622-628
62. Saed GM, Zhang W, Chegini N, Holmdahl L, Diamond MP. Transforming growth factor beta isoforms production by human peritoneal mesothelial cells after exposure to hypoxia. Am J Reprod Immunol 2000;43:285-291
63. Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261:4337-4345
64. Frank S, Madlener M, Werner S. Transforming growth factors beta1, beta2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem 1996;271:10188-10193
65. O'Kane S, Ferguson MW. Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol 1997;29:63-78
66. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995:108(Pt 3)985-1002
67. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286-1292
68. Chegini N, Gold LI, Williams RS, Masterson BJ. Localization of transforming growth factor beta isoforms TGF-beta 1, TGF-beta 2, and TGF-beta 3 in surgically induced pelvic adhesions in the rat. Obstet Gynecol 1994;83:449-454
69. Chegini N, Rong H, Bennett B, Stone IK. Peritoneal fluid cytokine and eicosanoid levels and their relation to the incidence of peritoneal adhesion. J Soc Gynecol Investig 1999;6:153-157
70. Williams RS, Rossi AM, Chegini N, Schultz G. Effect of transforming growth factor beta on postoperative adhesion formation and intact peritoneum. J Surg Res 1992;52:65-70
71. Diamond MP, Wirth JJ, Saed GM. PCBs enhance collagen I expression from human peritoneal fibroblasts. Fertil Steril 2008; in press
72. Rout UK, Saed GM, Diamond MP. Transforming growth factor-beta1 modulates expression of adhesion and cytoskeletal proteins in human peritoneal fibroblasts. Fertil Steril 2002;78:154-161
73. Cheong YC, Laird SM, Li TC, Shelton JB, Ledger WL, Cooke ID. Peritoneal healing and adhesion formation/reformation. Hum Reprod Update 2001;7:556-566
74. Miyake S, Yagita H, Maruyama T, Hashimoto H, Miyasaka N, Okumura K. Beta 1 integrin-mediated interaction with extracellular matrix proteins regulates cytokine gene expression in synovial fluid cells of rheumatoid arthritis patients. J Exp Med 1993;177:863-868
75. Werb Z, Tremble PM, Behrendtsen O, Crowley E, Damsky CH. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 1989;109:877-889
76. Gazvani MR, Christmas S, Quenby S, Kirwan J, Johnson PM, Kingsland CR. Peritoneal fluid concentrations of interleukin-8 in women with endometriosis: relationship to stage of disease. Hum Reprod 1998;13:1957-1961
77. Rout UK, Oommen K, Diamond MP. Altered expressions of VEGF mRNA splice variants during progression of uterine-peritoneal adhesions in the rat. Am J Reprod Immunol 2000;43:299-304
78. Molinas CR, Campo R, Dewerchin M, Eriksson U, Carmeliet P, Koninckx PR. Role of vascular endothelial growth factor and placental growth factor in basal adhesion formation and in carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice. Fertil Steril 2003;80(Suppl 2):803-811
79. Wiczyk HP, Grow DR, Adams LA, O'Shea DL, Reece MT. Pelvic adhesions contain sex steroid receptors and produce angiogenesis growth factors. Fertil Steril 1998;69: 511-516
80. Diamond MP, El-Hammady E, Munkarah A, Bieber EJ, Saed G. Modulation of the expression of vascular endothelial growth factor in human fibroblasts. Fertil Steril 2005;83: 405-409
81. Ferrara N, vis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25
82. Goldsmith HS, Griffith AL, Kupferman A, Catsimpoolas N. Lipid angiogenic factor from omentum. JAMA 1984; 252:2034-2036
83. Muschel RJ, Bernhard EJ, Garza L, McKenna WG, Koch CJ. Induction of apoptosis at different oxygen tensions: evidence that oxygen radicals do not mediate apoptotic signaling. Cancer Res 1995;55:995-998
84. Ladin DA, Hou Z, Patel D, et al. p53 and apoptosis alterations in keloids and keloid fibroblasts. Wound Repair Regen 1998;6:28-37
85. Sogawa K. Overview: hypoxia. Tanpakushitsu Kakusan Koso 1999;44:2470-2471
86. Stempien-Otero A, Karsan A, Cornejo CJ, et al. Mechanisms of hypoxia-induced endothelial cell death. Role of p53 in apoptosis. J Biol Chem 1999;274:8039-8045
87. DeCherney AH, diZerega GS. Clinical problem of intraperitoneal postsurgical adhesion formation following general surgery and the use of adhesion prevention barriers. Surg Clin North Am 1997;77:671-688
88. diZerega GS. Biochemical events in peritoneal tissue repair. Eur J Surg Suppl 1997;579:10-16
89. Brauner A, Hylander B, Wretlind B. Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1993;22:430-435
90. Brauner A, Hylander B, Wretlind B. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 27:402-408
91. Zemel D, Koomen GC, Hart AA, Ten Berge I, Struijk DG, Krediet RT. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 1993;122:686-696
92. Halme J. Release of tumor necrosis factor-alpha by human peritoneal macrophages in vivo and in vitro. Am J Obstet Gynecol 1989;161:1718-1725
93. Lowry SF. Cytokine mediators of immunity and inflammation. Arch Surg 1993;128:1235-1241
94. Mori H, Sawairi M, Nakagawa M, Itoh N, Wada K, Tamaya T. Peritoneal fluid interleukin-1 beta and tumor necrosis factor in patients with benign gynecologic disease. Am J Reprod Immunol 1991;26:62-67
95. Bauer J, Ganter U, Geiger T, et al. Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. Blood 1988;72: 1134-1140
96. Hirano T. Interleukin 6 and its receptor: ten years later. Int Rev Immunol 1998;16:249-284
97. Ivarsson ML, Holmdahl L, Falk P, Molne J, Risberg B. Characterization and fibrinolytic properties of mesothelial cells isolated from peritoneal lavage. Scand J Clin Lab Invest 1998;58:195-203
98. Whawell SA, Scott-Coombes DM, Vipond MN, Tebbutt SJ, Thompson JN. Tumour necrosis factor-mediated release of plasminogen activator inhibitor 1 by human peritoneal mesothelial cells. Br J Surg 1994;81:214-216
99. Saba AA, Godziachvili V, Mavani AK, Silva YJ. Serum levels of interleukin 1 and tumor necrosis factor alpha correlate with peritoneal adhesion grades in humans after major abdominal surgery. Am Surg 1998;64:734-736
100. Guerra-Infante FM, Flores-Medina S, Lopez-Hurtado M, et al. Tumor necrosis factor in peritoneal fluid from asymptomatic infertile women. Arch Med Res 1999;30: 138-143
101. Chegini N, Rong H, Bennett B, Stone IK. Peritoneal fluid cytokine and eicosanoid levels and their relation to the incidence of peritoneal adhesion. J Soc Gynecol Investig 1999;6:153-157
102. Mori H, Sawairi M, Nakagawa M, Itoh N, Wada K, Tamaya T. Peritoneal fluid interleukin-1 beta and tumor necrosis factor in patients with benign gynecologic disease. Am J Reprod Immunol 1991;26:62-67
103. Saed GM, Kruger M, Diamond MP. Expression of transforming growth factor-beta and extracellular matrix by human peritoneal mesothelial cells and by fibroblasts from normal peritoneum and adhesions: effect of Tisseel. Wound Repair Regen 2004;12:557-564
104. Buyalos RP, Funari VA, Azziz R, Watson JM, Martinez-Maza O. Elevated interleukin-6 levels in peritoneal fluid of patients with pelvic pathology. Fertil Steril 1992;58:302-306
105. Holschneider CH, Cristoforoni PM, Ghosh K, Punyasavatsut M, Abed E, Montz FJ. Endogenous versus exogenous IL-10 in postoperative intraperitoneal adhesion formation in a murine model. J Surg Res 1997;70:138-143